Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Other financing activities (2020)

Treace Medical Concepts (TMCI) has disclosed Other financing activities for 1 consecutive years, with $8000.0 as the latest value for Q1 2020.

  • For the quarter ending Q1 2020, Other financing activities changed N/A year-over-year to $8000.0, compared with a TTM value of $8000.0 through Dec 2021, changed N/A, and an annual FY2025 reading of $1.2 million, changed N/A over the prior year.
  • Other financing activities was $8000.0 for Q1 2020 at Treace Medical Concepts.
  • Across five years, Other financing activities topped out at $8000.0 in Q1 2020 and bottomed at $8000.0 in Q1 2020.